dengu
virus
denv
repres
signific
threat
human
health
global
economi
caus
widespread
frequent
epidem
transmit
femal
mosquito
denv
famili
four
known
serotyp
genet
antigen
relat
infect
one
denv
serotyp
typic
produc
asymptomat
mild
diseas
induc
longterm
immun
serotyp
howev
subsequ
exposur
differ
serotyp
may
result
moresever
diseas
character
dengu
hemorrhag
fever
dengu
shock
syndrom
often
attribut
antibodydepend
enhanc
overal
potenti
advers
diseas
outcom
due
immun
crossreact
complic
effort
produc
effect
vaccin
denv
famili
studi
aspect
infect
pathogenesi
number
revers
genet
system
gener
member
flaviviru
famili
includ
denv
approach
provid
power
tool
manipul
viral
genom
given
insight
viral
protein
function
virul
determin
viral
immun
evas
host
specif
virushost
interact
revers
genet
system
also
facilit
improv
research
methodolog
develop
report
assay
well
mean
produc
viruslik
particl
live
attenu
vaccin
addit
infecti
clone
provid
opportun
explor
clonal
popul
denv
rel
mutat
versu
mutant
spectrum
typic
observ
laboratori
passag
stock
togeth
tool
critic
build
foundat
understand
denv
diseas
pathogenesi
yet
current
system
use
sever
obstacl
remain
denv
revers
genet
system
flaviviru
clone
difficult
maintain
bacteria
often
result
sequenc
rearrang
mutat
reduc
express
toxic
element
viral
genom
sever
approach
employ
improv
propag
includ
use
lowcopynumb
plasmid
insert
bacteri
yeast
artifici
chromosom
disrupt
promot
region
viral
cdna
well
microbefre
propag
approach
howev
method
often
diminish
yield
produc
chang
viral
sequenc
requir
signific
extran
effort
reduc
overal
util
approach
importantli
mani
revers
genet
system
report
signific
attenu
rel
control
wildtyp
wt
virus
despit
similar
consensu
sequenc
overal
result
highlight
obstacl
use
revers
genet
system
studi
denv
diseas
pathogenesi
studi
extend
character
dengu
viru
serotyp
infecti
clone
compar
contrast
growth
antigen
properti
molecularli
clone
recombin
wildtyp
importantli
deriv
clone
maintain
equival
replic
complet
antibodi
bind
fidel
wildtyp
strain
use
tetrapartit
molecular
clone
insert
known
envelop
protein
domain
edi
neutral
epitop
demonstr
effici
gain
neutral
function
howev
introduc
chang
simultan
ablat
two
known
antibodi
bind
site
disrupt
bind
neutral
togeth
result
illustr
util
newli
develop
infecti
clone
platform
studi
denv
immun
exchang
function
complex
epitop
denv
strain
simultan
gain
new
neutral
properti
strain
ablat
primari
neutral
antigen
site
recombin
infecti
clone
synthes
panel
four
continu
cdna
segment
span
entir
genom
fig
base
sequenc
laboratori
strain
west
pac
segment
flank
class
ii
restrict
endonucleas
site
cleav
palindrom
sequenc
asymmetr
overhang
overhang
permit
direct
assembl
cleav
fragment
gener
fulllength
viral
cdna
except
ablat
restrict
site
see
materi
method
sequenc
directli
reconstitut
wildtyp
wt
laboratori
strain
ligat
cdna
fragment
use
templat
produc
fulllength
viral
rna
electropor
mosquito
cell
demonstr
transfect
effici
fulllength
transcript
result
infecti
center
assay
indic
low
stabl
infect
fig
sever
day
cell
cultur
supernat
contain
progeni
virion
harvest
passag
cell
gener
work
viru
stock
rna
isol
infect
cell
verifi
rel
parent
wildtyp
strain
use
genom
length
analysi
find
differ
consensu
amino
acid
sequenc
similarli
endpoint
titer
cell
fig
found
notabl
differ
virus
deriv
wildtyp
regard
replic
cell
wildtyp
infectiousclonederiv
viru
maintain
similar
size
foci
follow
infect
fig
togeth
result
indic
replic
deficit
focu
format
deficit
observ
wildtyp
infecti
clone
viru
previous
describ
revers
genet
system
denv
hamper
replic
attenu
rel
wildtyp
strain
despit
ident
consensu
sequenc
determin
whether
attenu
rel
wildtyp
viru
growth
curv
complet
mosquito
cell
time
cours
fig
data
indic
wildtyp
replic
equival
peak
focusform
unit
day
infect
fig
percent
infect
cell
also
demonstr
signific
differ
wildtyp
infecti
clone
nearli
infect
observ
day
infect
fig
next
examin
replic
human
monocytederiv
cell
line
stabli
express
dcsign
dendrit
cellspecif
intercellular
adhes
molecul
nonintegrin
known
denv
attach
factor
fig
similar
mosquito
cell
line
observ
differ
replic
wildtyp
dcsignexpress
cell
result
demonstr
detect
attenu
clone
rel
wildtyp
strain
either
insect
human
cell
antibodi
bind
neutral
critic
issu
denv
pathogenesi
human
infecti
clone
parent
wt
strain
must
display
surfac
architectur
epitop
compar
display
antibodi
epitop
enzymelink
immunosorb
assay
elisa
perform
use
panel
monoclon
antibodi
mab
parent
wildtyp
strain
see
tabl
supplement
materi
mab
deriv
patient
bind
envelop
domain
edi
region
extend
edi
domain
ii
edii
hing
region
elisa
mab
produc
strong
equival
bind
wildtyp
infecti
clone
fig
similarli
edi
ediii
ediii
hing
region
epitop
mab
also
bound
similarli
wildtyp
fig
final
mab
ediii
antibodi
also
bound
similarli
wildtyp
fig
togeth
result
indic
display
antibodi
epitop
wildtyp
control
viru
also
test
bind
denv
serotyp
monoclon
antibodi
tabl
begin
antibodi
mab
fail
bind
either
wildtyp
fig
similarli
mab
also
fail
bind
wildtyp
strain
effici
bind
fig
final
mab
edi
antibodi
specif
show
bind
either
iter
fig
togeth
combin
monoclon
data
result
indic
surfac
architectur
epitop
wildtyp
strain
observ
equival
antibodi
bind
wildtyp
viru
elisa
neutral
even
sensit
function
assay
compar
virus
small
chang
bind
conform
may
induc
enhanc
versu
neutral
assay
must
equival
infecti
clone
wildtyp
viru
justifi
use
rdenvic
vaccin
immunogen
studi
use
focu
reduct
neutral
test
frnt
examin
abil
welldefin
mab
block
viru
infect
three
monoclon
antibodi
percent
neutral
nearli
ident
wildtyp
fig
c
similar
elisa
result
monoclon
antibodi
denv
serotyp
unabl
neutral
either
clone
wildtyp
viru
fig
f
extend
studi
flowbas
neutral
assay
percent
infect
result
reveal
overlap
neutral
wildtyp
follow
monoclon
antibodi
incub
fig
c
addit
none
denv
serotypespecif
antibodi
provid
signific
reduct
viral
infect
fig
f
togeth
result
match
elisa
data
indic
antibodi
neutral
fidel
infecti
clone
wildtyp
virus
two
independ
neutral
assay
use
rdenvic
studi
antibodi
respons
specif
epitop
gener
mutant
viru
incorpor
epitop
backbon
viru
typespecif
strongli
neutral
mab
isol
nonhuman
primat
infect
highresolut
structur
bound
e
protein
led
identif
residu
within
edi
interact
antibodi
tabl
amino
acid
five
conserv
remain
residu
replac
manipul
plasmid
infecti
clone
fig
tabl
mab
bound
neutral
viru
fig
c
parent
clone
wildtyp
recogn
fig
c
result
confirm
success
transfer
conform
epitop
epitop
mab
overlap
known
typespecif
epitop
recogn
human
neutral
mab
importantli
onethird
predict
contact
residu
replac
viru
fig
tabl
insert
epitop
partial
disrupt
epitop
result
reduct
effect
concentr
complet
ablat
bind
fig
similarli
neutral
assay
indic
nearli
lost
abil
neutral
mutant
fig
mab
smaller
percentag
epitop
disrupt
viru
fig
tabl
addit
contact
residu
ediii
neighbor
dimer
maintain
fig
despit
smaller
percentag
bind
still
reduc
fig
neutral
mostli
lost
fig
contrast
monoclon
antibodi
target
ediii
epitop
fig
signific
reduct
elisa
bind
rel
wildtyp
viru
infecti
clone
fig
addit
mab
maintain
robust
neutral
indic
mainten
epitop
within
mutant
viru
fig
summari
introduct
epitop
residu
creat
viru
lead
effici
display
heterolog
epitop
disrupt
two
nativ
typespecif
epitop
result
illustr
util
infecti
clone
transfer
denv
epitop
serotyp
identifi
function
consequ
conserv
epitop
within
transfer
amino
acid
region
number
revers
genet
system
dengu
virus
develop
signific
obstacl
includ
replic
attenu
sequenc
alter
well
labor
costintens
techniqu
limit
util
studi
character
novel
molecular
clone
platform
pattern
coronaviru
system
describ
addit
detail
includ
transcript
infect
recombin
viru
phenotyp
vitro
gener
panel
contigu
cdna
span
entir
genom
divid
revers
genet
system
overcom
toxic
element
within
allow
propag
bacteria
importantli
direct
assembl
vitro
transcript
allow
electropor
fulllength
infecti
rna
directli
correspond
wildtyp
viru
sequenc
result
viru
deriv
infecti
clone
maintain
similar
replic
multipl
cell
type
fig
g
well
complet
fidel
regard
antibodi
bind
viru
neutral
fig
build
previou
epitop
swap
mutant
employ
revers
genet
system
gener
viral
mutant
display
known
monoclon
antibodi
epitop
gain
monoclon
antibodi
bind
neutral
donor
sequenc
strain
howev
mutant
viru
also
disrupt
bind
neutral
two
monoclon
antibodi
despit
retain
major
target
antigen
residu
tabl
fig
monoclon
antibodi
maintain
effect
bind
neutral
fig
data
highlight
opportun
cost
domain
swap
even
context
partial
epitop
disrupt
overal
result
also
illustr
util
newli
develop
infecti
clone
system
platform
studi
infect
pathogenesi
immun
denv
vaccin
field
revers
genet
system
amplifi
opportun
viru
design
alreadi
explor
previou
work
lab
util
infecti
clone
defin
transfer
critic
antibodi
bind
epitop
identifi
structur
analysi
case
describ
recombin
viru
display
heterolog
epitop
preserv
major
neutral
epitop
addit
previou
work
use
infecti
clone
abl
transfer
part
mab
epitop
result
partial
gain
bind
neutral
loss
bind
mab
importantli
mab
epitop
distinct
epitop
transplant
coupl
data
current
studi
approach
disrupt
epitop
within
context
live
viru
highlight
independ
power
approach
quickli
valid
structur
predict
key
residu
importantli
full
character
viral
epitop
portabl
denv
serotyp
open
new
approach
vaccin
develop
work
defin
ration
design
chimer
viru
use
mabenvelop
structur
interact
identifi
residu
associ
mab
epitop
suffici
gain
bind
neutral
chang
lead
disrupt
multipl
overlap
epitop
highlight
potenti
problem
must
address
denv
vaccin
design
interestingli
despit
maintain
nearli
twothird
epitop
chimer
viru
bind
neutral
almost
complet
lost
indic
critic
residu
determin
antibodi
interact
among
chang
anoth
mab
maintain
much
larger
percentag
epitop
chimer
viru
lost
smaller
amount
bind
yet
still
lost
nearli
complet
neutral
suggest
remain
epitop
still
partial
bound
interact
insuffici
fulli
neutral
viru
structureguid
design
could
identifi
addit
residu
expand
transplant
epitop
fulli
ablat
mab
polyclon
bind
neutral
togeth
data
illustr
util
map
epitop
use
combin
structur
rever
genet
similar
approach
employ
human
noroviru
resourc
appli
gener
diagnost
reagent
creat
map
epitop
ideal
design
chimer
bival
vaccin
produc
broadspectrum
neutral
critic
issu
denv
pathogenesi
move
beyond
vaccin
immun
infecti
clone
system
provid
opportun
contribut
area
denv
research
explor
virushost
interact
complic
attenu
tradit
clonederiv
viru
system
maintain
replic
equival
wildtyp
strain
allow
examin
impact
specif
point
mutat
viral
protein
delet
without
complic
interpret
baselin
clone
attenu
addit
area
infecti
clone
system
may
use
resourc
identifi
virul
determin
host
specif
viral
protein
function
rna
structur
element
well
test
antivir
therapeut
overal
revers
genet
system
character
studi
repres
major
resourc
studi
infect
pathogenesi
build
previou
report
clone
system
provid
sever
import
advantag
studi
includ
robust
propag
bacteria
fidel
wildtyp
sequenc
absenc
replic
attenu
importantli
antibodi
bind
viru
neutral
indic
uniform
antigen
wildtyp
strain
permit
epitop
map
coupl
structur
studi
revers
genet
system
manipul
produc
chimer
vaccin
harbor
conserv
epitop
multipl
serotyp
unlik
neutral
epitop
four
serotyp
could
combin
singl
viabl
chimer
denv
viru
possibl
two
bival
virus
contain
neutral
epitop
four
serotyp
eg
could
gener
advanc
offer
promis
strategi
produc
broad
protect
denv
famili
recombin
west
pac
infecti
clone
construct
use
fourcdna
clone
strategi
previous
describ
briefli
genom
divid
four
fragment
subclon
separ
cdna
plasmid
uniqu
type
ii
restrict
endonucleas
cleavag
site
end
fragment
pflmi
site
remov
use
standard
molecular
techniqu
promot
introduc
end
plasmid
fragment
plasmid
dna
grown
escherichia
coli
cell
purifi
plasmid
dna
enzym
digest
purifi
ligat
togeth
dna
ligas
infecti
genomelength
cap
viral
rna
transcript
gener
polymeras
rna
electropor
cell
incub
day
cell
cultur
supernat
contain
viru
harvest
centrifug
maximum
speed
remov
cellular
debri
passag
onto
cell
gener
passag
one
viru
stock
mutant
viru
gener
predict
contact
residu
identifi
differ
tabl
plasmid
fragment
redesign
encod
chang
envelop
protein
creat
new
plasmid
digest
ligat
wt
plasmid
b
c
describ
gener
mutant
viru
cell
cultur
previous
describ
group
cell
grown
gibco
minim
essenti
medium
mem
dcsignexpress
cell
maintain
rpmi
media
supplement
fetal
bovin
serum
fb
cell
lower
infect
media
supplement
nonessenti
amino
acid
medium
also
supplement
lglutamin
media
addit
supplement
uml
penicillin
streptomycin
amphotericin
b
cell
incub
cell
cultur
plate
plate
seed
cell
confluent
time
infect
cell
growth
media
remov
viru
stock
serial
dilut
ad
cell
h
gentl
rock
incub
cell
overlaid
methylcellulos
optimem
gibco
supplement
fb
nonessenti
amino
acid
uml
penicillin
streptomycin
amphotericin
b
incub
day
incub
overlay
remov
cell
wash
phosphatebuff
salin
pb
fix
methanol
cell
block
nonfat
dri
milk
pb
block
buffer
incub
h
antiprm
mab
anti
mab
dilut
block
buffer
cell
wash
two
time
pb
incub
h
horseradish
peroxidas
hrp
conjug
goat
antimous
antibodi
sigma
dilut
block
buffer
plate
wash
two
time
pb
foci
develop
use
trueblu
hrp
substrat
kpl
cell
electropor
rna
dilut
optimem
gibco
ad
confluent
monolay
cell
overlaid
methylcellulos
incub
day
incub
cell
fix
stain
describ
percentag
electropor
cell
capabl
make
viabl
infecti
viru
calcul
follow
number
focinumb
electropor
cell
plate
determin
amount
viru
cell
produc
cell
inocul
multipl
infect
moi
everi
h
cell
cultur
supernat
harvest
volum
replac
fresh
medium
frozen
titer
viru
sampl
determin
describ
determin
kinet
cell
becom
infect
cell
inocul
moi
everi
h
cell
cultur
medium
remov
cell
wash
pb
fix
permeabil
probe
antiprm
mab
conjug
alexa
fluor
infect
cell
quantifi
use
guava
flow
cytomet
millipor
cell
infect
initi
infect
everi
h
sampl
cell
harvest
fix
stain
describ
cell
plate
coat
either
ngwell
mous
mab
ngwell
human
mab
overnight
plate
wash
trisbuff
salin
tween
tbst
block
nonfat
dri
milk
tbst
block
buffer
equal
quantiti
viru
previous
titrat
enzymelink
immunosorb
assay
elisa
ad
incub
h
plate
wash
primari
human
mab
dilut
fourfold
block
buffer
ad
plate
h
plate
wash
alkalin
phosphat
ap
conjug
secondari
antibodi
ad
h
plate
wash
develop
use
pnitrophenyl
phosphat
substrat
color
chang
quantifi
spectrophotometri
previous
describ
focu
reduct
neutral
test
frnt
cell
cultur
plate
seed
cell
confluent
time
infect
mab
dilut
fourfold
mix
focusform
unit
ffu
viru
incub
h
incub
virusmab
mixtur
ad
cell
h
gentl
rock
overlay
ad
cell
incub
day
cell
fix
stain
describ
flowbas
neutral
assay
mab
dilut
fourfold
mix
viru
previous
titrat
equal
infect
mab
present
incub
h
incub
virusmab
mixtur
ad
cell
h
cell
pellet
wash
two
time
fresh
medium
incub
h
incub
cell
fix
permeabil
stain
describ
growth
curv
wildtyp
sequenc
deriv
genbank
access
number
monoclon
antibodi
synthes
deposit
protein
data
bank
sequenc
pdb
identifi
id
shown
bracket
mab
